Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
作者信息
Shapiro R, Jordan M L, Scantlebury V P, Vivas C, Gritsch H A, McCauley J, McQuitty D, Randhawa P, Irish W, McMichael J, Hakala T R, Simmons R L, Fung J J, Starzl T E
机构信息
University of Pittsburgh, Thomas E. Starzl Transplantation Institute, Pennsylvania, USA.
出版信息
Transplant Proc. 1998 Jun;30(4):1375-7. doi: 10.1016/s0041-1345(98)00280-2.
Abstract
摘要
相似文献
1
Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的肾移植患者停用类固醇后的结局。
Transplant Proc. 1998 Jun;30(4):1375-7. doi: 10.1016/s0041-1345(98)00280-2.
2
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的成年肾移植患者停用类固醇后的结果。
Transplant Proc. 2001 Feb-Mar;33(1-2):1235-6. doi: 10.1016/s0041-1345(00)02402-7.
3
Weaning of immunosuppression in liver transplant recipients.肝移植受者免疫抑制的撤减
Transplantation. 1997 Jan 27;63(2):243-9. doi: 10.1097/00007890-199701270-00012.
4
5
Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.肾移植后基于他克莫司的简单免疫抑制方案：二联与三联疗法的大型多中心比较
Transplant Proc. 2002 Feb;34(1):89-91. doi: 10.1016/s0041-1345(01)02680-x.
6
A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.他克莫司/泼尼松与他克莫司/泼尼松/霉酚酸酯用于肾移植的前瞻性随机试验：1年精算随访
Transplant Proc. 1999 Feb-Mar;31(1-2):1134. doi: 10.1016/s0041-1345(98)01935-6.
7
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.肾移植患者从基于他克莫司的治疗方案中停用类固醇。
Transplant Proc. 2002 Aug;34(5):1707-8. doi: 10.1016/s0041-1345(02)02991-3.
8
A pilot trial of tacrolimus, sirolimus, and steroids in renal transplant recipients.他克莫司、西罗莫司和类固醇在肾移植受者中的一项试点试验。
Transplant Proc. 2002 Aug;34(5):1651-2. doi: 10.1016/s0041-1345(02)02966-4.
9
Pediatric renal transplantation under tacrolimus-based immunosuppression.基于他克莫司的免疫抑制下的小儿肾移植
Transplantation. 1999 Jan 27;67(2):299-303. doi: 10.1097/00007890-199901270-00020.
10
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group.种族和免疫抑制对肾移植的影响：一项美国多中心随机试验的三年生存结果。FK506肾移植研究组
Transplant Proc. 1998 Jun;30(4):1355-8. doi: 10.1016/s0041-1345(98)00274-7.
引用本文的文献
1
Steroid avoidance or withdrawal for kidney transplant recipients.肾移植受者的类固醇避免或停用
Cochrane Database Syst Rev. 2016 Aug 22;2016(8):CD005632. doi: 10.1002/14651858.CD005632.pub3.
2
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?肾移植中无类固醇维持免疫抑制：是时候将其视为标准疗法了吗？
Kidney Int. 2009 Oct;76(8):825-30. doi: 10.1038/ki.2009.248. Epub 2009 Jul 22.
3
Corticosteroid avoidance in pediatric renal transplantation.小儿肾移植中避免使用皮质类固醇
Pediatr Nephrol. 2005 Mar;20(3):418-26. doi: 10.1007/s00467-004-1786-4. Epub 2005 Feb 3.
4
Corticosteroid avoidance in pediatric renal transplantation: can it be achieved?小儿肾移植中避免使用皮质类固醇：能否实现？
Paediatr Drugs. 2004;6(5):273-87. doi: 10.2165/00148581-200406050-00002.
5
Calcineurin inhibitors in renal transplantation: what is the best option?肾移植中的钙调神经磷酸酶抑制剂：最佳选择是什么？
Drugs. 2003;63(15):1535-48. doi: 10.2165/00003495-200363150-00002.
6
Outcome after steroid withdrawal in adult renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的成年肾移植患者停用类固醇后的结果。
Transplant Proc. 2001 Feb-Mar;33(1-2):1235-6. doi: 10.1016/s0041-1345(00)02402-7.
7
Outcome after steroid withdrawal in pediatric renal transplant patients receiving tacrolimus-based immunosuppression.接受以他克莫司为基础的免疫抑制治疗的小儿肾移植患者停用类固醇后的结果。
Transplantation. 2000 Sep 15;70(5):760-4. doi: 10.1097/00007890-200009150-00008.
8
Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.他克莫司：其在器官移植管理中的药理学及治疗应用的进一步更新
Drugs. 2000 Feb;59(2):323-89. doi: 10.2165/00003495-200059020-00021.
9
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.他克莫司免疫抑制下停用类固醇后胰腺移植的结果。
Transplantation. 2000 Jan 27;69(2):265-71. doi: 10.1097/00007890-200001270-00012.
本文引用的文献
1
Tacrolimus in pediatric renal transplantation.他克莫司在小儿肾移植中的应用
Transplantation. 1996 Dec 27;62(12):1752-8. doi: 10.1097/00007890-199612270-00010.
2
Tacrolimus in renal transplantation.他克莫司在肾移植中的应用。
Transplant Proc. 1996 Aug;28(4):2117-8.
3
Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.肾移植术后27至29年的嵌合现象与供体特异性无反应性
Transplantation. 1993 Jun;55(6):1272-7. doi: 10.1097/00007890-199306000-00012.
4
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance.全器官移植后的细胞迁移与嵌合现象：移植物接受的基础
Hepatology. 1993 Jun;17(6):1127-52.
5
Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.免疫抑制药物所允许的供体细胞嵌合现象：器官移植的新视角。
Immunol Today. 1993 Jun;14(6):326-32. doi: 10.1016/0167-5699(93)90054-o.
6
FK 506 in the management of nephrotic syndrome after renal transplantation.FK506在肾移植后肾病综合征管理中的应用
Transplant Proc. 1993 Feb;25(1 Pt 2):1351-4.
7
8
A prospective randomized trial of FK506-based immunosuppression after renal transplantation.肾移植后基于FK506免疫抑制的前瞻性随机试验。
Transplantation. 1995 Feb 27;59(4):485-90. doi: 10.1097/00007890-199559040-00007.
9
A prospective, randomized trial of FK-506 in renal transplantation--a comparison between double- and triple-drug therapy.FK-506在肾移植中的前瞻性随机试验——双药疗法与三药疗法的比较。
Clin Transplant. 1994 Dec;8(6):508-15.
10
FK506 in pediatric kidney transplantation--primary and rescue experience.FK506在小儿肾移植中的应用——初次及挽救性治疗经验
Pediatr Nephrol. 1995;9 Suppl(Suppl):S43-8. doi: 10.1007/BF00867683.
Zotero 插件